علاج متلازمة السرطانوي مع عبء الأعراض الشديد وأمراض قلب السرطانوي

References

DOI: 10.1111/jne.13146

• RCS may be divided into either non-aggressive or aggressive, based on symptoms burden (< or ≥ 4 BM/day, and/or < or ≥ 5 flushing episodes/day, respectively) together with disease stability (stable or progressive), hepatic burden (< or ≥ 50% liver involvement), and/or the presence of CHD.
• Aggressive: high symptom burden, tumor progression, hepatic tumour burden > 50% and/or CHD.
• Aggressive CS: more than four bowel movements (BM)/day and/or more than five flushing episodes/day.
• Everolimus · Interferon